Date: 2018-09-04
Type of information: Nomination
Compound: executive vice-president
Company: Tmunity Therapeutics, (USA - PA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On September 4, 2018, Tmunity Therapeutics announced the appointment of Graeme Bell as Chief Financial Officer (CFO) and Executive Vice President. Mr. Bell formerly served in CFO roles at Intellia Therapeutics, AnacorPharmaceuticals, and at Merck & Co., Inc. in US and UK operations.
- In his role at Tmunity, Mr. Bell will be responsible for all aspects of the company’s financial operations, including relationships with the capital markets. He will also oversee IT and other operational aspects, and work closely with the University of Pennsylvania and external partners.
- During his tenure with Intellia Therapeutics, Mr. Bell held the position of CFO and was also responsible for operations, IT and investor relations. Prior to Intellia, he was CFO and oversaw operations at Anacor Pharmaceuticals. Mr. Bell also previously served as CFO at Merck & Co., Inc. in US and UK operations and held finance positions of increasing responsibility in manufacturing, commercial and corporate functions.
- Mr. Bell holds a Master of Business Administration degree from the University of Durham (UK) and is a Fellow of the Chartered Institute of Management Accountants.
Financial terms:
Latest news:
Is general: Yes
